GRAIL Poaches New CEO From Roche, Genentech Post author:Sam Post published:December 13, 2017 Post category:BioPharma Four months after Jeff Huber stepped down as CEO of GRAIL, the company has tapped his replacement. Source: BioSpace You Might Also Like Semler Scientific Reports Fourth Quarter And Annual 2016 Financial Results March 9, 2017 Medtronic Receives CE Mark For Its Next Generation Cardiac Resynchronization Therapy-Pacemakers February 23, 2017 Amag Investors Cheer as Biotech Wins Second Drug Approval This Month February 15, 2018
Medtronic Receives CE Mark For Its Next Generation Cardiac Resynchronization Therapy-Pacemakers February 23, 2017